MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
A map has been created to show the location of all of the sites participating in the STAMPEDE study. Find the STAMPEDE map here.
STAMPEDE is a Multi-Arm Multi-Stage (MAMS) trial design, in which new comparisons can be introduced to the current model. The STAMPEDE trial has now completed recruitment. The final day of patient randomisation was completed on 31st March 2023. Follow-up for the final patients will continue for a couple of years.
Have another question or looking for more information? why not check out the STAMPEDE Training Suite for the training slides detailing information on STAMPEDE.
STAMPEDE
MRC Clinical Trials Unit at UCL
2nd Floor
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.stampede@ucl.ac.uk
STAMPEDE
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy
See the latest News in STAMPEDE through the link to the right.